Reversibility of antimicrobial resistance in respiratory isolates in HIV-positive Cambodian children after 36 months of HAART [16]

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 1, 2007, Pages 194-197

  Shahum, Andrea ^a,b   Benca, George ^a,b   Duong, Lina Seng ^a,b   Augustin, Andrea ^a   Havlik, Suzanne ^a   Liska, Anne ^b,c   Kalavsky, Erich ^b   Beno, Paul ^b   Krcmery Jr , Vladimir ^a,c  

^a House of Family Max   (Cambodia)

^b St Elizabeth School of Health and Social Sciences   (Slovakia)

^c University Hospital Nitra   (Slovakia)

Author keywords

Antibiotic resistance; Immune reconstitution; MRSA

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; CEFIXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; EFAVIRENZ; ERYTHROMYCIN; GENTAMICIN; ISONIAZID; LAMIVUDINE; NEVIRAPINE; PENICILLIN G; PYRAZINAMIDE; RIFAMPICIN; STAVUDINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CAMBODIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EXPOSURE; ENTEROBACTER; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KLEBSIELLA; LETTER; LUNG TUBERCULOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAMBODIA; CHILD; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HIV INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; RESPIRATORY TRACT DISEASES; TIME FACTORS;

EID: 34447556783     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm133     Document Type: Letter

References (4)

1. Chintu C, Bhat GJ, Walker AS et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): A double-blind randomised placebo-controlled trial. Lancet 2004; 364: 1865-71.
2. Dankner WM, Lindsey JC, Levin MJ et al. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Pediatr Infect Dis J 2001; 20: 40-8.
3. Hughes WT, Leoung G, Kramer F et al. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N Engl J Med 1993; 328: 1521-7.
4. Hughes WT, Dankner WM, Yogev R et al. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV Infection. Clin Infect Dis 2005; 40: 136-45.